Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
1000 g IM daily or every other day for 12 weeks, then 1000 g once weekly for 48 weeks
Retatrutideis an investigational peptide-based medication designed primarily forweight loss, obesity treatment, and blood sugar control
Erlotinib was first approved by the Food and Drug Administration on November 18, 2004, as a monotherapy for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
Selank is a synthetic heptapeptide derived from tuftsin (Thr-Lys-Pro-Arg) with a stabilizing Gly-Pro C-terminal sequence
US$ 27.77
US$ 25.49
US$ 28.84
US$ 21.82
